Bepotastine yields lasting relief
February 1st 2011Pooled results from two prospective, multicenter, double-masked, placebo-controlled studies show a multi-modal anti-allergy product, bepotastine besilate ophthalmic solution 1.5%, provides rapid and long-lasting clinically significant improvement in allergen-induced ocular itching.
Olopatadine: Once-daily dosing benefit
February 1st 2011Improved quality of life for patients with allergic conjunctivitis is the name of the game for Stephen V. Scoper, MD, who uses olopatadine hydrochloride ophthalmic solution 0.2% to treat this patient population because of the increased compliance that the drug affords with its once-daily dosing requirement.
Adjustable-focus eyeglasses lauded
January 26th 2011Superfocus LLC has received 2011 iF International Forum Design Award in the medical device category. The award recognizes the world?s first adjustable-focus eyeglasses (Superfocus) providing focus at all distances through the entire field of view, according to the honoree.
AAO: Headache, tired eyes with 3-D games may indicate eye disorder
January 26th 2011Healthy children who consistently develop headaches or tired eyes or cannot clearly see images when playing 3-D games on handheld digital products may have a vision or eye disorder, according to the American Academy of Ophthalmology (AAO). ?If such problems occur, the [AAO] recommends that the child be given a comprehensive exam by an ophthalmologist,? the organization said in a statement.